Clinical predictive factors of pathologic tumor response after preoperative chemoradiotherapy in rectal cancer

Chi Hwan Choi; Won Dong Kim; Sang Jeon Lee; Woo-Yoon Park
September 2012
Radiation Oncology Journal;Sep2012, Vol. 30 Issue 3, p99
Academic Journal
Purpose: The aim of this study was to identify clinical predictive factors for tumor response after preoperative chemoradiotherapy (CRT) in rectal cancer. Materials and Methods: The study involved 51 patients who underwent preoperative CRT followed by surgery between January 2005 and February 2012. Radiotherapy was delivered to the whole pelvis at a dose of 45 Gy in 25 fractions, followed by a boost of 5.4 Gy in 3 fractions to the primary tumor with 5 fractions per week. Three different chemotherapy regimens were used (5-fluorouracil and leucovorin, capecitabine, or tegafur/uracil). Tumor responses to preoperative CRT were assessed in terms of tumor downstaging and pathologic complete response (ypCR). Statistical analyses were performed to identify clinical factors associated with pathologic tumor response. Results: Tumor downstaging was observed in 28 patients (54.9%), whereas ypCR was observed in 6 patients (11.8%). Multivariate analysis found that predictors of downstaging was pretreatment relative lymphocyte count (p = 0.023) and that none of clinical factors was significantly associated with ypCR. Conclusion: Pretreatment relative lymphocyte count (%) has a significant impact on the pathologic tumor response (tumor downstaging) after preoperative CRT for locally advanced rectal cancer. Enhancement of lymphocyte-mediated immune reactions may improve the effect of preoperative CRT for rectal cancer.


Related Articles

  • Neoadjuvant radiation and chemotherapy in rectal cancer does not increase postoperative complications. Valero, G.; Luján, J. A.; De las Heras, M.; Pellicer, E.; Serrano, A.; Parrilla, P.; Hernández, Q. // International Journal of Colorectal Disease;Nov2003, Vol. 18 Issue 6, p495 

    Background and aims. Neoadjuvant radiation and chemotherapy in rectal cancer reduces local recurrences and increases the rate of conservative sphincter surgery. However, an increase in postoperative morbidity and mortality has also been observed. This study analyzed the operative difficulty and...

  • Current Thoughts on the Surgical Treatment of Rectal Cancer. Golfmatis, B. C.; Delikaris, P. C.; Haritopoulos, N. K.; Setakis, N. G. // American Journal of Gastroenterology;Jan1976, Vol. 65 Issue 1, p68 

    From August, 1971 to May, 1974, 52 cases of rectal cancer belonging to different groups, according to Mason's classification, were seen at the First Surgical Department, University of Athens Medical School. In the majority of the eases the tumor was removed by combined abdomino-perineal...

  • Negative impact of pretreatment anemia on local control after neoadjuvant chemoradiotherapy and surgery for rectal cancer. Hyebin Lee; Hee Chul Park; Won Park; Doo Ho Choi; Young-Il Kim; Young Suk Park; Joon Oh Park; Ho-Kyung Chun; Woo-Yong Lee; Hee Cheol Kim; Seong Hyeon Yun; Yong Beom Cho; Yoon Ah Park // Radiation Oncology Journal;Sep2012, Vol. 30 Issue 3, p117 

    Purpose: Although anemia is considered to be a contributor to intra-tumoral hypoxia and tumor resistance to ionizing radiation in cancer patients, the impact of pretreatment anemia on local control after neoadjuvant concurrent chemoradiotherapy (NACRT) and surgery for rectal cancer remains...

  • P-0181CAPECITABINE AND RADIOTHERAPY AS PREOPERATIVE TREATMENT IN PATIENTS WITH STAGE II-III RECTAL CANCER. Ruiz-Vozmediano, Julia; González-Flores, Encarnación; Conde-Herrero, Verónica; González-Astorga, Beatriz; González-Vicente, Aranzazu; García-García, Javier; Linares, Isabel; Pérez, Juan Ramón Delgado; Castillo-Portellano, Lucia; González-Rivas, Cynthia // Annals of Oncology;Jun2013, Vol. 24 Issue suppl_4, piv87 

    No abstract available.

  • Cancer du rectum: radiochimiothérapie pré-opératoire et nouvelles voies de recherche. Lorchel, Fabrice; Bosset, J.-F. // Oncologie;dec2005, Vol. 7 Issue 8, p613 

    Preoperative chemoradiotherapy should now be considered as a new standard in treatment of locally advanced rectal cancer. As compared to preoperative radiotherapy or postoperative chemoradiotherapy it definitively increases local control while the acute toxicity is moderate. This approach has...

  • Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious? Glynne-Jones, R.; Grainger, J.; Harrison, M.; Ostler, P.; Makris, A. // British Journal of Cancer;2/13/2006, Vol. 94 Issue 3, p363 

    Neoadjuvant chemotherapy (NACT) is a term originally used to describe the administration of chemotherapy preoperatively before surgery. The original rationale for administering NACT or so-called induction chemotherapy to shrink or downstage a locally advanced tumour, and thereby facilitate more...

  • Prognostic Significance of Nodal Disease Following Preoperative Radiation for Rectal Adenocarcinoma. Rinkus, Keith M.; Russell, Gregory B.; Levine, Edward A. // American Surgeon;May2002, Vol. 68 Issue 5, p482 

    The administration of preoperative radiation (Pre-Op) therapy for adenocarcinoma of the rectum is evolving. The prognostic value of nodal disease found after preoperative therapy is unclear. The purpose of this study is to evaluate the impact of Pre-Op therapy on nodal staging and thus prognosis...

  • The timing of surgery after preoperative short-course S-1 chemoradiotherapy with delayed surgery for T3 lower rectal cancer. Beppu, Naohito; Matsubara, Nagahide; Noda, Masashi; Yamano, Tomoki; Doi, Hiroshi; Kamikonya, Norihiko; Yamanaka, Naoki; Yanagi, Hidenori; Tomita, Naohiro // International Journal of Colorectal Disease;Dec2014, Vol. 29 Issue 12, p1459 

    Purpose: The purpose of this study was to analyze the influence of variations in clinical practice regarding the timing of surgery with short-course chemoradiotherapy with delayed surgery (SCRT-delay) for lower rectal cancer. Methods: A total of 171 patients with T3 N0-2 lower rectal cancer...

  • Reduced luminal circumference of tumors plays a key role in anorectal function during the early period after neoadjuvant chemoradiation therapy in rectal cancer patients. Kye, Bong-Hyeon; Kim, Hyung-Jin; Cho, Hyeon-Min; Kim, Jun-Gi; Kim, Sung; Shim, Byoung-Yong // International Journal of Colorectal Disease;Apr2015, Vol. 30 Issue 4, p465 

    Purpose: The deterioration of anorectal function after neoadjuvant chemoradiation therapy (nCRT) combined with surgery for rectal cancer has not been well defined. The aim of this study was to evaluate the relationship between the tumor response to nCRT and changes in anorectal function during a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics